硫酸软骨素市场:按产地、地区 - 市场规模、份额、展望、机会分析,2023-2030 年
市场调查报告书
商品编码
1330169

硫酸软骨素市场:按产地、地区 - 市场规模、份额、展望、机会分析,2023-2030 年

Chondroitin Sulfate Market, By Source (Bovine, Swine, Poultry ), and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3个工作天内

价格
简介目录

硫酸软骨素是一种在促进软骨、骨骼和结缔组织健康方面发挥重要作用的分子。 硫酸软骨素用于治疗骨关节炎等各种骨骼疾病。 骨关节炎是一种痛苦的疾病,会导致关节发炎和僵硬。 这种疾病的发生涉及多种因素,包括老化、遗传、不良饮食习惯和肥胖。 硫酸软骨素被广泛用作治疗骨关节炎的自然疗法。 此外,它还充当抗炎剂。

市场动态:

由于对营养补充品的需求不断增加,全球硫酸软骨素市场正在成长。 这主要是由于人口老化的增加,老年人更容易患骨关节炎等骨骼相关疾病。 推动市场的另一个因素是越来越多地使用硫酸软骨素作为眼药水的成分,以帮助治疗干眼症。 此外,它是动物饲料中的常见添加剂,可促进生长和减轻压力。

另一方面,原物料价格的波动预计将限制市场成长。

本研究的主要特点

  • 本报告详细分析了全球硫酸软骨素市场,并提供了以 2022 年为基准年的预测期(2023-2030 年)的市场规模和復合年增长率 (CAGR%)。
  • 它也揭示了各个细分市场的潜在收入机会,并解释了该市场有吸引力的投资主张矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和批准、市场趋势、区域前景、主要参与者采取的竞争策略等的重要见解。
  • 本报告根据公司亮点、产品组合、主要成就、财务表现和策略等参数,介绍了全球硫酸软骨素市场的主要参与者。
  • 本研究涵盖的主要公司包括 TSI 集团有限公司、青岛万图民生物製品有限公司、河北三鑫实业集团、Bioiberica S.A.U.、Sigma-Aldrich, Inc.、Sino Siam Biotechnique Company Limited、Bio-gen Extracts Private Limited、SEIKAGAKU CORPORATION、BRF 和ZPD。
  • 该报告的见解将使行销人员和公司高层能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 《全球硫酸软骨素市场报告》面向该产业的各个利害关係人,例如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球硫酸软骨素市场的各种策略矩阵,将有助于利害关係人做出决策。

目录

第1章研究目的与前提

  • 研究目的
  • 先决条件
  • 缩写

第2章市场概述

  • 报告摘要
    • 市场定义和范围
  • 执行摘要
  • 连贯的机会地图 (COM)

第3章市场动态、法规与趋势分析

  • 市场动态
    • 骨关节炎增加
    • 原物料价格不稳定
    • 製药业的扩张
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第 4 章硫酸软骨素的世界市场 - 冠状病毒 (COVID-19) 流行的影响

  • COVID-19 的流行病学
  • 供给面与需求面分析
  • 经济影响

第5章硫酸软骨素的全球市场:依来源划分,2023-2030

  • 家禽

第 6 章硫酸软骨素全球市场(按地区),2023-2030 年

  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东
  • 非洲

第7章竞争态势

  • TSI Group Ltd.
  • Qingdao Wan Toulmin Biological Products Co., Ltd
  • HeBei SanXin Industrial Group
  • Bioiberica S.A.U.
  • Sigma-Aldrich, Inc.
  • Sino Siam Biotechnique Company Limited
  • Bio-gen Extracts Private Limited
  • SEIKAGAKU CORPORATION
  • BRF
  • ZPD

第 8 章部分

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6000

Chondroitin sulfate is an important molecule that plays a key role in promoting healthy cartilage, bones, and connective tissues. It is used in the treatment of various skeletal conditions, such as osteoarthritis. Osteoarthritis is a painful condition, which leads to inflammation and stiffness of joints. Several factors are responsible for the emergence of the disease, including age, genetics, poor diet, and obesity. Chondroitin sulfate is widely used as a natural remedy to treat osteoarthritis. Moreover, it also acts as an anti-inflammatory agent.

Market Dynamics:

The global chondroitin sulfate market is growing on the account of increasing demand for dietary supplements. This is mainly due to the increase in the aging population, which makes them more susceptible to bone-related diseases such as osteoarthritis. Another factor driving the market is the growing use of chondroitin sulfate as an ingredient in eye drops, which helps in treating dry eyes. In addition, it is a common additive in animal feed to enhance growth and reduce stress.

On the other hand, fluctuating price of raw materials is expected to restrict the market growth.

Key features of the study:

  • This report provides in-depth analysis of the global chondroitin sulfate market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global chondroitin sulfate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include TSI Group Ltd., Qingdao Wan Toulmin Biological Products Co., Ltd, HeBei SanXin Industrial Group, Bioiberica S.A.U., Sigma-Aldrich, Inc., Sino Siam Biotechnique Company Limited, Bio-gen Extracts Private Limited, SEIKAGAKU CORPORATION, BRF, and ZPD
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global chondroitin sulfate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chondroitin sulfate market

Detailed Segmentation:

  • Global Chondroitin Sulfate Market, By Source
    • Bovine
      • Nutraceuticals
      • Pharmaceuticals
      • Animal Feed
      • Personal Care & Cosmetics
      • Others
    • Swine
      • Nutraceuticals
      • Pharmaceuticals
      • Animal Feed
      • Personal Care & Cosmetics
      • Others
    • Poultry
      • Shark
      • Synthetic
  • Global Chondroitin Sulfate Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Central and South America
    • Middle East
    • Africa
  • Company Profiles
    • TSI Group Ltd.
    • Qingdao Wan Toulmin Biological Products Co., Ltd
    • HeBei SanXin Industrial Group
    • Bioiberica S.A.U.
    • Sigma-Aldrich, Inc.
    • Sino Siam Biotechnique Company Limited
    • Bio-gen Extracts Private Limited
    • SEIKAGAKU CORPORATION
    • BRF
    • ZPD

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Source
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing prevalence of osteoarthritis
    • Volatile price of raw materials
    • Expanding pharmaceutical industry
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Chondroitin Sulfate Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Chondroitin Sulfate Market , By Source, 2023-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Bovine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Nutraceuticals
  • Pharmaceuticals
  • Animal Feed
  • Personal Care & Cosmetics
  • Others
  • Swine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Nutraceuticals
  • Pharmaceuticals
  • Animal Feed
  • Personal Care & Cosmetics
  • Others
  • Poultry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
  • Shark
  • Synthetic

6. Global Chondroitin Sulfate Market , By Region, 2023-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2023 - 2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Mn)
  • Central and South America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Mn)
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Mn)
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Mn)

7. Competitive Landscape

  • TSI Group Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Qingdao Wan Toulmin Biological Products Co., Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • HeBei SanXin Industrial Group
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bioiberica S.A.U.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sigma-Aldrich, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sino Siam Biotechnique Company Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bio-gen Extracts Private Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • SEIKAGAKU CORPORATION
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BRF
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • ZPD
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

8. Section

  • Research Methodology
  • About us